HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nuclear-envelope nucleoside triphosphatase kinetics and mRNA transport following brain ischemia and reperfusion.

AbstractSTUDY HYPOTHESIS:
We attempted to determine whether the reduced egress of mRNA from brain nuclei following in vivo ischemia and reperfusion is caused by direct damage to the nuclear pore-associated NTPase that impairs the system for nuclear export of polyadenylated, or poly(A)+, mRNA.
DESIGN:
Prospective animal study.
INTERVENTIONS:
NTPase activity and poly(A)+ mRNA transport were studied in nuclear envelope vesicles (NEVs) prepared from canine parietal cortex isolated after 20 minutes of ischemia or 20 minutes of ischemia and 2 or 6 hours of reperfusion.
RESULTS:
Brain NEV NTPase Michaelis-Menten constant (Km) and maximum uptake velocity (Vmax) and the ATP-stimulated poly(A)+ mRNA egress rates were not significantly affected by ischemia and reperfusion. In vitro exposure of the NEVs to the OH. radical-generating system completely abolished NTPase activity.
CONCLUSION:
We conclude that brain ischemia and reperfusion do not induce direct inhibition of nucleocytoplasmic transport of poly(A)+ mRNA. This suggests that the nuclear membrane is not exposed to significant concentrations of OH. radical during reperfusion.
AuthorsB R Tiffany, B C White, G S Krause
JournalAnnals of emergency medicine (Ann Emerg Med) Vol. 25 Issue 6 Pg. 809-17 (Jun 1995) ISSN: 0196-0644 [Print] United States
PMID7755206 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • RNA, Messenger
  • Hydroxyl Radical
  • Acid Anhydride Hydrolases
  • Nucleoside-Triphosphatase
Topics
  • Acid Anhydride Hydrolases (pharmacokinetics)
  • Animals
  • Biological Transport
  • Brain Ischemia (metabolism)
  • Dogs
  • Heart Arrest (metabolism)
  • Hydroxyl Radical (metabolism)
  • Nuclear Envelope (metabolism)
  • Nucleoside-Triphosphatase
  • Prospective Studies
  • RNA, Messenger (metabolism)
  • Reperfusion

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: